{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:00:36Z","timestamp":1770235236778,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.vaccine.2020.10.068","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T11:00:38Z","timestamp":1603882838000},"page":"7877-7879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A clinical perspective of the U.S. anti-vaccination epidemic: Considering marginal costs and benefits, CDC best practices guidelines, free riders, and herd immunity"],"prefix":"10.1016","volume":"38","author":[{"given":"Michael G.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Ballinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence D.","family":"Frenkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"C. William","family":"Hinnant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin W.","family":"Zucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.10.068_b0005","doi-asserted-by":"crossref","first-page":"A68","DOI":"10.1016\/j.vaccine.2010.02.037","article-title":"The structure, role, and procedures of the US Advisory Committee on Immunization Practices (ACIP)","volume":"28","author":"Smith","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.068_b0010","first-page":"175","article-title":"Addressing vaccine hesitancy: Clinical guidance for primary care physicians working with parents","volume":"65","author":"Shen","year":"2019","journal-title":"Can Fam Phys"},{"issue":"4","key":"10.1016\/j.vaccine.2020.10.068_b0015","doi-asserted-by":"crossref","first-page":"e835","DOI":"10.1542\/peds.2013-2365","article-title":"Effective messages in vaccine promotion: a randomized trial","volume":"133","author":"Nyhan","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2020.10.068_b0020","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/jlme.12307","article-title":"Physician dismissal of families who refuse vaccination: An ethical assessment","volume":"43","author":"Diekema","year":"2015","journal-title":"J Law Med Ethics"},{"issue":"10","key":"10.1016\/j.vaccine.2020.10.068_b0025","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archpedi.159.10.929","article-title":"Dismissing the family who refuses vaccines: a study of pediatrician attitudes","volume":"159","author":"Flanagan-Klygis","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"12","key":"10.1016\/j.vaccine.2020.10.068_b0030","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00127-016-1286-4","article-title":"An interpretative phenomenological analysis (IPA) of coercion towards community dwelling older adults with dementia: findings from Mysore studies of natal effects on ageing and health (MYNAH)","volume":"51","author":"Danivas","year":"2016","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.10.068_b0035","article-title":"Vaccination externalities","volume":"7","author":"Boulier","year":"2007","journal-title":"BE J Econ Anal Policy"},{"issue":"9","key":"10.1016\/j.vaccine.2020.10.068_b0040","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.vaccine.2020.01.042","article-title":"Performance of the United States Vaccine Injury Compensation Program (VICP): 1988\u20132019","volume":"38","author":"Thompson","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.10.068_b0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.publhealth.25.101802.123046","article-title":"Lessons learned from public health mass media campaigns: marketing health in a crowded media world","volume":"25","author":"Randolph","year":"2004","journal-title":"Annu Rev Public Health"},{"issue":"3","key":"10.1016\/j.vaccine.2020.10.068_b0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jama.2019.7445","article-title":"Preserving civility in vaccine policy discourse: a way forward","volume":"322","author":"Poland","year":"2019","journal-title":"JAMA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:48:06Z","timestamp":1759402086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20313888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":10,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0264410X20313888"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.068","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A clinical perspective of the U.S. anti-vaccination epidemic: Considering marginal costs and benefits, CDC best practices guidelines, free riders, and herd immunity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}